Enlitic Completes Technical Validation of Ensight Platform
Released
Released
Announcement PDF
ASX Announcement
Enlitic, Inc.
ARBN 672 254 027
1
13 January 2026
Enlitic Completes Technical Validation of
Ensight Platform
Enlitic, Inc. (ASX: ENL) (Enlitic) has completed a technical validation of its Ensight medical
imaging data standardisation platform on Oracle Cloud Infrastructure (OCI), utilising AMD
EPYC™ processors.
The validation was conducted to confirm that Ensight operates reliably, consistently, and
at scale within a modern cloud environment suitable for varying clinical, operational, and
research workflows.
Summary of Validation Activities and Outcomes
Testing was performed using anonymised medical imaging datasets representative of
real-world healthcare environments, covering a range of anatomical regions and clinical
contexts.
The validation assessed Ensight’s ability to process varying data volumes across multiple
system configurations, reflecting the operational conditions encountered by hospitals,
radiology providers and research organisations.
The validation activities confirmed:
- Correct execution of medical imaging data standardisation and normalisation functions
- Stable and consistent system performance aligned with results achieved on prior
infrastructure
- Reliable operation within defined system specifications
- Successful integration with OCI storage and managed database services
Customer and Partner Relevance
The validation activities demonstrated that Ensight can be deployed on OCI with AMD
EPYC™ processors while maintaining functional integrity and performance consistency.
This provides healthcare customers with an additional validated infrastructure option for
managing and standardising large-scale medical imaging datasets in secure cloud
environments.
“Our work with AMD and Oracle has validated that Ensight performs as intended on a
modern, scalable cloud platform,” said Michael Sistenich, CEO of Enlitic. “This gives our
Enlitic, Inc.
ARBN 672 254 027
2
customers confidence that they can deploy Ensight in cloud environments that meet their
performance, security, and scalability requirements.”
“The healthcare industry continues to adopt high-performance computing to address
complex data challenges,” said Tony Nunes, Senior Manager, Healthcare & Life Sciences,
AMD Server Business Unit. “This collaboration with Enlitic demonstrates how AMD EPYC
processors can support demanding medical imaging and AI-enabled workloads in cloud
environments.”
“OCI delivers a secure and high-performance cloud platform for healthcare and life
sciences organisations,” said Dan Spellman, Vice President, AI and OCI, Healthcare &
Life Sciences, Oracle. “Enlitic’s validation of Ensight on OCI highlights how cloud
infrastructure can support reliable, large-scale healthcare data operations.”
This announcement has been authorised for release by the Board of Enlitic, Inc.
Enquiries
Enlitic Investor Relations
Australia:
invest_au@enlitic.com
About Enlitic
Enlitic is a software company that uses artificial intelligence to develop software products
that manage medical imaging data in radiology (such as MRI, CT scans, X-ray and
ultrasound images) and licences such products to healthcare providers. Enlitic’s products
(including its current product offering and product suite under development) seek to
standardise, protect, integrate, and analyse data to create the foundation of a real-world
evidence platform that can improve clinical workflows, increase efficiencies, and expand
capacity. Read more at enlitic.com.
Enlitic’s CDIs are traded on ASX in reliance on the safe harbour provisions of Regulation S
under the US Securities Act of 1933 as amended, and in accordance with the procedures
established pursuant to the provisions of a no action letter dated 7 January 2000 given
to ASX by the staff at the US Securities and Exchange Commission. The relief was given
subject to certain procedures and conditions described in the no action letter. One of the
conditions is that the issuer provides notification of the Regulation S status of its securities
in communications such as this announcement.
Share your feedback
Discover